OP0248 Responder Analysis of the Effects of Abaloparatide (Parathyroid Hormone Related Peptide) and...
OP0248 Responder Analysis of the Effects of Abaloparatide (Parathyroid Hormone Related Peptide) and Teriparatide on Bone Mineral Density in Postmenopausal Women with Osteoporosis: Results of the Active Trial
About this item
Full title
Author / Creator
Miller, P.D. , Hattersley, G. , Lau, E. , Alexandersen, P. , Hala, T. , Mustatea, S. , Nedergaard, B.S. , Krogsaa, A. , Slessinger, J. , Zerbini, C. , Valter, I. , Visockiene, Z. , Jendrych, B. , Kulak, C.M. , Marquez, F. , Harris, A.G. , Williams, G.C. , Hu, M.-Y. , Black, D.M. , Riis, B.J. , Russo, L. and Christiansen, C.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
More information
Scope and Contents
Contents
BackgroundEarly gains in total hip BMD are desirable to improve hip strength early in the treatment of osteoporosis.ObjectivesTo determine if women treated with 18-months of abaloparatide (ABL) were more likely to increase BMD than those treated with either TPTD or placebo (PBO), we performed a responder analysis comparing the percentage of subject...
Alternative Titles
Full title
OP0248 Responder Analysis of the Effects of Abaloparatide (Parathyroid Hormone Related Peptide) and Teriparatide on Bone Mineral Density in Postmenopausal Women with Osteoporosis: Results of the Active Trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1901803473
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1901803473
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2015-eular.4908
